)Imetaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease, J Neurol Neurosurg Psychiatr, vol.67, issue.123, pp.189-94, 1999. ,
Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG, J Nucl Med, vol.41, pp.71-78, 2000. ,
Profound cardiac sympathetic denervation occurs in Parkinson disease, Brain Pathol, vol.15, pp.29-34, 2005. ,
Decreased cardiac uptake of MIBG is a potential biomarker for the presence of Lewy bodies, J Neurol, vol.254, pp.21-29, 2007. ,
diagnostic and pathophysiological impact of myocardial MIBG scintigraphy in parkinson's disease, Parkinsons Dis, 2010. ,
Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders, Mov Disord, vol.26, pp.1218-1242, 2011. ,
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis, Clin Auton Res, vol.22, pp.43-55, 2012. ,
123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis, Parkinsonism Relat Disord, vol.18, pp.494-500, 2012. ,
Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology, Eur J Nucl Med Mol Imaging, vol.37, pp.1802-1814, 2010. ,
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatr, vol.55, pp.181-185, 1992. ,
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium, Neurology, vol.65, pp.1863-72, 2005. ,
Second consensus statement on the diagnosis of multiple system atrophy, Neurology, vol.71, pp.670-676, 2008. ,
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop, Neurology, vol.47, pp.1-9, 1996. ,
Criteria for the diagnosis of corticobasal degeneration, Neurology, vol.80, pp.496-503, 2013. ,
Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?, Eur Rev Med Pharmacol Sci, vol.17, pp.1326-1359, 2013. ,
Cardiac Neurotransmission Imaging*, J Nucl Med, vol.42, pp.1062-76, 2001. ,
Diagnostic cutoff points for 123 I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease, Eur J Nucl Med Mol Imaging, vol.38, pp.1139-1185, 2011. ,
Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease, J Neurol Sci, vol.240, pp.15-24, 2006. ,
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease, Mov Disord, vol.22, pp.1004-1012, 2007. ,
Differences in myocardial sympathetic degeneration and the clinical features of the subtypes of Parkinson's disease, J Clin Neurosci, vol.18, pp.922-927, 2011. ,
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with 123 ,
, Mol Med Rep, vol.6, pp.1337-1379, 2012.
Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease, Parkinsonism Relat Disord, vol.15, pp.706-714, 2009. ,
PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes, J Nucl Med, vol.47, pp.1769-77, 2006. ,
Cerebral and extracranial neurodegeneration are strongly coupled in PArkinson's disease, Open Neurol J, vol.1, pp.1-4, 2007. ,
Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET, Eur J Nucl Med Mol Imaging, vol.37, pp.3-11, 2010. ,
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease, Eur J Neurol, vol.16, pp.174-82, 2009. ,